首页 › 基金 › Saturn V Capital Management LP › OVID
Saturn V Capital Management LP 对 OVID 的持仓历史
OVID THERAPEUTICS INC · 医疗保健
Saturn V Capital Management LP 在 Q2 2026 的 13F 申报中披露持有 OVID(OVID THERAPEUTICS INC)663,060 股,市值约 US$1.8M,约占其申报组合的 0.26%,在其申报持仓中市值排名第 23 位。 Saturn V Capital Management LP 最近 3 个申报季度中有 3 个季度披露了 OVID 持仓,最早可追溯至 Q4 2025。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Saturn V Capital Management LP 对 OVID 的持仓演变
Saturn V Capital Management LP 于 Q4 2025 首次披露 OVID 持仓:2,500,000 股(约 US$4.1M)。 该持仓在 Q1 2026 达到峰值 4,166,666 股,市值约 US$9.2M。 在 3 次申报中,Saturn V Capital Management LP 1 次增持、1 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 663,060 股、市值约 US$1.8M,环比减持 -3,503,606 股。。 持仓曾出现大幅变动:Q1 2026 增持约 67% (随后一个季度股价上涨 21%)、Q2 2026 减持约 84% (随后一个季度股价下跌 7%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2025 | 2.50M | $4.08M | 新进 |
| Q1 2026 | 4.17M | $9.25M | 增持 |
| Q2 2026 | 663.06K | $1.78M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 OVID 与 13F 数据
OVID(OVID THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 52 只申报持有 OVID,申报仓位最大的包括:Affinity Asset Advisors, LLC (US$27.3M), ADAR1 Capital Management, LLC (US$20.0M), SILVERARC CAPITAL MANAGEMENT, LLC (US$8.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 OVID 的基金
- Affinity Asset Advisors, LLC 10.14M 股 · $27.29M · Q2 2026
- ADAR1 Capital Management, LLC 7.42M 股 · $19.95M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 3.10M 股 · $8.34M · Q2 2026
- STEMPOINT CAPITAL LP 2.42M 股 · $6.50M · Q2 2026
- Ikarian Capital, LLC 2.27M 股 · $6.11M · Q2 2026
- Propel Bio Management, LLC 1.12M 股 · $3.00M · Q2 2026
- Rosalind Advisors, Inc. 1.11M 股 · $2.98M · Q2 2026
- Sio Capital Management, LLC 1.01M 股 · $2.70M · Q2 2026
- Ally Bridge Group (NY) LLC 624.56K 股 · $1.68M · Q2 2026
更多关于 Saturn V Capital Management LP
常见问题
How long has Saturn V Capital Management LP held OVID?
Saturn V Capital Management LP has disclosed OVID holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Saturn V Capital Management LP's current position in OVID?
As of Q2 2026, Saturn V Capital Management LP holds 663.06K shares of OVID (OVID THERAPEUTICS INC), valued at $1.78M, representing 0.26% of its reported portfolio and ranking #23.
Has Saturn V Capital Management LP been buying or selling OVID?
In the latest 13F filing (Q2 2026), Saturn V Capital Management LP reduced its position in OVID. The position peaked in Q1 2026 at 4.17M shares.
Which other funds hold OVID?
Other major institutional holders of OVID include Affinity Asset Advisors, LLC, ADAR1 Capital Management, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.